G42 Healthcare announces partnership with WHOOP

G42 Healthcare announces partnership with WHOOP

Abu Dhabi-based G42 Healthcare has partnered with Boston-based wearable technology firm, WHOOP, for the Whoop4Humanity initiative that offers volunteers participating in the Phase III trials of the COVID-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics. This is the first trial of its kind to feature wearable technology and will include thousands of volunteers who are participating in the trials.The Whoop4Humanity initiative ensures that volunteers who now join the clinical trials at ADNEC in Abu Dhabi and the Al Qarain Center in Sharjah, including those coming in for the second dose, can further enhance their participation in the trails by using the new wearable devices which will enable them to check their daily heart rate, respiratory rate, heart rate variability, sleep performance,